Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Impaired Object Handling during Bimanual Task Performance in Multiple Sclerosis.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Mast cells and inflammation.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Current options for the treatment of optic neuritis.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Effects of yoga interventions on fatigue: a meta-analysis.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.

Pages